| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.9 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.9 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.9 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |